Key result
Percutaneous mitral valve prostheses offer an alternative to repair techniques for high-risk patients with severe mitral incompetence, though early mortality remains high.
Percutaneous mitral valve replacement is an evolving technology that offers complete correction of mitral regurgitation for high-risk or inoperable patients, though early mortality remains a challenge.
Hypothesis-generating for percutaneous mitral valve replacement in complex anatomies; prospective trials needed to reduce early mortality before clinical adoption.
During the last few years, there has been significant advances in the treatment of patients with severe mitral incompetence either too high risk for surgery or inoperable, this because of the improvements in percutaneous mitral valve prostheses, as alternative to the transcatheter mitral repair techniques. Percutaneous mitral valve replacement offers several advantages over the repair techniques, such as the opportunity to treat mitral valve with different anatomic characteristics, even the more complex ones, and the occasion to correct completely mitral regurgitation. The development of such prostheses has been a long process, still on the making. During the initial stages of the procedure, the transapical approach was preferred. On the other hand, the transseptal approach, which has already been used in some patients, is the proper development path for this transcatheter technique. Many valvular prostheses have been produced, each using a different mechanism for secure anchoring and elimination of regurgitation. Early mortality for this procedure, although decreasing since the preliminary studies, is still high, not only because the technology is still in its initial phase but also for the very high risk of the patients treated. It is foreseeable, though, that in the near future, as the technology and patients selection improves, better results will follow.
No takes yet. Share an insight, caveat, or question.
Bellini et al. (2020) conducted a review in Severe mitral incompetence. Percutaneous mitral valve prostheses vs. Transcatheter mitral repair techniques was evaluated. Percutaneous mitral valve prostheses offer an alternative to repair techniques for high-risk patients with severe mitral incompetence, though early mortality remains high.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: